Skip to main content

Antidepressant Use and Bleeding Events

    Basic Details
    Date Posted
    Medical Product
    selective serotonin reuptake inhibitor (SSRI)
    serotonin-norepinephrine reuptake inhibitor (SNRI)
    Health Outcome(s)
    bleeding event
    gastrointestinal hemorrhage
    intracerebral hemorrhage (ICH)

    Modular program-based one-time assessment of the use of antidepressants (SSRIs, SNRIs, and tricyclics) and risk of bleeding events among members with a pre-existing condition of depression and members with no pre-existing condition requirements. The query was run against the Mini-Sentinel Distributed Database (MSDD) for the time period of January 1, 2009 through December 31, 2011.  Modular programs are adaptable standardized programs. Results were generated using Modular Program 3, version 1.0; click here for more information.  Queries were distributed in February 2012. This report includes data from 18 Data Partners.
    If you are using a web page screen reader and are unable to access this document, please use the Contact Us page for assistance or send an email requesting assistance to
    The information contained on this website is provided as part of FDA's commitment to place knowledge acquired from the Mini-Sentinel pilot in the public domain as soon as possible. Please read the disclaimer.

    Additional Details
    FDA Center
    Time Period
    January 1, 2009 to December 31, 2011
    Analysis Type
    Population / Cohort
    All individuals
    Data Sources
    Mini-Sentinel Distributed Database (MSDD)